These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35787250)

  • 41. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.
    McMahon A; Robb NC
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21168. PubMed ID: 33052872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening Programs for SARS-CoV-2 Infections on a University Campus - Austin, Texas, September 30-November 30, 2020.
    Nerhood KJ; James ER; Hardin A; Bray JE; Hines TS; Young AE; Bhavnani D
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1201-1205. PubMed ID: 34473686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Coyle P; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Tang P; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
    PLoS Med; 2021 Dec; 18(12):e1003879. PubMed ID: 34914711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study.
    Flacco ME; Acuti Martellucci C; Soldato G; Carota R; Fazii P; Caponetti A; Manzoli L
    J Public Health (Oxf); 2022 Dec; 44(4):e475-e478. PubMed ID: 34492110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.
    Boufidou F; Medić S; Lampropoulou V; Siafakas N; Tsakris A; Anastassopoulou C
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.
    Suleyman G; Fadel R; Patel K; Shadid AM; Stuart HBC; Kattula M; Janis A; Maki M; Chao S; Alangaden G; Brar I
    J Infect Public Health; 2023 Aug; 16(8):1262-1268. PubMed ID: 37302273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
    Teran RA; Gagner A; Gretsch S; Lauritsen J; Galanto D; Walblay K; Ruestow P; Korban C; Pacilli M; Kern D; Black SR; Tabidze I
    Emerg Infect Dis; 2023 Nov; 29(11):2257-2265. PubMed ID: 37877555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
    Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
    Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection.
    Hoeggerl AD; Nunhofer V; Weidner L; Lauth W; Zimmermann G; Badstuber N; Grabmer C; Kartal O; Jungbauer C; Neureiter H; Held N; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
    Infect Dis (Lond); 2024 Nov; 56(11):954-964. PubMed ID: 38869944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 reinfections.
    Fabiánová K; Kynčl J; Vlčková I; Jiřincová H; Košťálová J; Liptáková M; Orlíková H; Šebestová H; Limberková R; Macková B; Malý M
    Epidemiol Mikrobiol Imunol; 2021; 70(1):62-67. PubMed ID: 33853339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 reinfections during the Delta and Omicron waves.
    Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
    Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
    Cortellini A; Aguilar-Company J; Salazar R; Bower M; Sita-Lumsden A; Plaja A; Lee AJX; Bertuzzi A; Tondini C; Diamantis N; Martinez-Vila C; Prat A; Apthorp E; Gennari A; Pinato DJ
    Br J Cancer; 2022 Nov; 127(10):1787-1792. PubMed ID: 35995934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
    Rodríguez-Grande C; Estévez A; Palomino-Cabrera R; Molero-Salinas A; Peñas-Utrilla D; Herranz M; Sanz-Pérez A; Alcalá L; Veintimilla C; Catalán P; Martínez-Laperche C; Alonso R; Muñoz P; Pérez-Lago L; de Viedma DG;
    Emerg Infect Dis; 2023 Jun; 29(6):1154-1161. PubMed ID: 37130503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.
    Simon V; Kota V; Bloomquist RF; Hanley HB; Forgacs D; Pahwa S; Pallikkuth S; Miller LG; Schaenman J; Yeaman MR; Manthei D; Wolf J; Gaur AH; Estepp JH; Srivastava K; Carreño JM; Cuevas F; ; Ellebedy AH; Gordon A; Valdez R; Cobey S; Reed EF; Kolhe R; Thomas PG; Schultz-Cherry S; Ross TM; Krammer F
    mSphere; 2022 Jun; 7(3):e0017922. PubMed ID: 35586986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Zmarzły N; Rojczyk E; Madej K; Sobański D; Staszkiewicz R; Ossowski P; Boroń-Kaczmarska A; Zapletal-Pudełko K; Boroń D; Grabarek BO
    Med Sci Monit; 2023 Mar; 29():e939452. PubMed ID: 36964642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.